ClinicalTrials.gg
CompletedNCT00812448Updated Nov 26, 2009

Catechin Containing Mask for the Prevention of Influenza Infection

An interventional study of tea catechin extracts in Influenza Infection, sponsored by University of Shizuoka. Completed at 2 sites in Japan. Open to participants aged 20 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-11-26.

Sponsored by University of Shizuoka · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
20 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 42 studies in Influenza, Human with a site in Japan — 4 open to participants now, 4 under way, 3 of them phase 3. Influenza, Human · Japan.

Enrollment
19th of 40
180 · median 169
Started
2008
with 2 others
No phase
5 of 42
1 open now
Registered
4th of 42
by date
Lead sponsor
3 of 42
University of Shizuoka

Among the 42 studies in Influenza, Human with a site in Japan, this one is the 19th largest by enrollment of the 40 interventional ones that give a count, is one of 3 that started in 2008, is one of 5 with no phase, and was the 4th registered.

Influenza, Human

2,361 studies on the registry are indexed under Influenza, Human; 186 are open to participants now.

Browse Influenza, Human studies →

Open to participants now

4 of the 42 studies in Influenza, Human with a site in Japan are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Japan have not opened yet or have stopped. Only those recruiting at a site in Japan →

Who these studies take

Of the 124 Influenza, Human studies recruiting now, 67 (54%) set no upper age limit and 47 (38%) stop at 75 or younger; 34 take children under 18; 69 take healthy volunteers.

This study: 20 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Influenza, Human with a site in Japan, or all of them as a file.
02

Study summary

The purpose of this study is to evaluate the effects of catechin extracts containing mask on prevention of influenza infection.

Read the detailed description

Catechins are the major components of tea flavonoids and are reported to possess physiological activities such as antiviral effects. Recent in-vitro experimental studies have revealed that tea catechin extracts possess the effects on the prevention of influenza infection. However, a limited number of studies have been conducted on the clinical effects. Based on these backgrounds, we designed a prospective randomized controlled study to evaluate the effects of tea catechin extracts containing mask on the prevention of influenza infection.

03

Conditions studied

  • Influenza Infection

Browse trials for

Keywords

  • prophylaxis
  • influenza infection
  • catechins
  • prophylaxis of influenza infection
04

Who can participate

Ages eligible
20 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Possible to wearing mask for three months
  • Possible to fill out a questionnaire personally
  • Obtained written before participation

Exclusion criteria

Exclusion Criteria:

  • Possessing some infectious diseases in need of therapy
  • Possessing tea or catechin allergy
  • diagnosed as inadequate for other reasons to participate the study by principal investigator
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (actual)

Study arms

  • Experimental
    tea catechin extracts containing mask

    wearing the tea catechin extracts containing mask

    Dietary Supplement: tea catechin extracts

Interventions

  • Dietary supplementtea catechin extracts

    catechins are composed of tea catechin extracts available in grren tea supplements

06

What researchers measure

Primary outcomes

  1. the incidence rate of influenza infection during the study

    Time frame: assessed at each month

Secondary outcomes

  1. the incidence rates of upper respiratory tract infections

    Time frame: assessed at each month

  2. the severity of the symptoms and the duration of the cold among incident cases

    Time frame: assessed at each month

  3. he incidence-free time for influenza or upper respiratory tract infections after the intervention

    Time frame: assessed at each month

07

Study locations

2 sites
  • Seirei Hamamatsu General Hospital
    Hamamatsu, Shizuoka, Japan
  • University of Shizuoka
    Shizuoka, 422-8526, Japan
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2008, a primary completion of Nov 2009 and a completion of Nov 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 18, 2008
First posted
Dec 22, 2008
Start
Dec 2008
Primary completionActual
Nov 2009
CompletionActual
Nov 2009
Last update
Nov 26, 2009
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 26, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00812448
Lead sponsor
University of Shizuoka
Collaborators
Seirei Hamamatsu General Hospital, Hamamatsu University
First posted
Dec 22, 2008
Start date
Dec 2008
Primary completion
Nov 2009
Completion
Nov 2009
Last update
Nov 26, 2009

Study contacts

Hiroshi Yamada, MD,PhD
study chair · University of Shizuoka

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion